title: Cryptococcus neoformans in tropical northern Australia: predominantly variant gattii with good outcomes.
abstract: BACKGROUND
  Infection with Cryptococcus neoformans is common in the Northern Territory of Australia. Disease is life threatening and treatment is prolonged and often complicated by the need for surgery and difficulties with medical therapy.
  
  
  OBJECTIVE
  To document incidence, demography, risk factors, clinical features and outcomes of infection and to determine differences between gattii and neoformans varieties.
  
  
  METHODS
  Case records of all patients (n = 35) diagnosed with cryptococcal infection at the Royal Darwin Hospital between 1976 and 1992 were reviewed retrospectively. Current status of patients was ascertained. Variety identification of isolates was determined by growth in canavanine-glycine-bromthymol blue agar.
  
  
  RESULTS
  Of the 35 patients, 23 had meningitis, ten had pneumonia, one had a dermal infection and one had fungaemia with no obvious focus. Twelve (52%) meningitis cases and two (20%) pneumonia cases had no predisposing disease. Thirteen (57%) meningitis cases had concomitant pulmonary cryptococcosis. Twenty-nine patients with Aboriginal and six were Caucasian, with a relative risk for Aboriginals compared with non-Aboriginals of 20.6 (95% CI 8.6-49.5). Arnhemland was the commonest location of infection, with an annual incidence in Aboriginals of 0.14/1000. Fourteen (78%) of 18 isolates tested were C. neoformans var. gattii. Management was characterised by the frequent need for adjunctive surgery and prolonged or repeat courses of systemic antifungal therapy. Despite this, long-term outcomes are encouraging with a mortality of 14% overall and 9% in meningitis patients. The river red gum (Eucalyptus camaldulensis) has a limited distribution in Arnhemland and ongoing studies are seeking alternative environmental sources of C. neoformans var. gattii.
authors.affiliation: Royal Darwin Hospital, Casuarina, NT, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Fisher
authors.forename: J
authors.initials: J
authors.lastname: Burrow
authors.forename: D
authors.initials: D
authors.lastname: Lo
authors.forename: B
authors.initials: B
authors.lastname: Currie
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003453:Cryptococcosis / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D003455:Cryptococcus neoformans / Q000145:classification; D005260:Female; D006801:Humans; D015994:Incidence; D007223:Infant; D008172:Lung Diseases, Fungal / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D008297:Male; D016921:Meningitis, Fungal / Q000175:diagnosis / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D008875:Middle Aged; D015876:Northern Territory / Q000453:epidemiology; D012307:Risk Factors